pharma-analytics

Ranks the opportunity spaces in the India Cardiac market where Cipla has a sustainable right to win. A deterministic engine computes every figure; the model only narrates what the tools return.

Pharma commercial analytics project — SQL Server star schema + Power BI dashboard covering product, geography, channel, concentration, sales-force, and time-trend analysis.

End-to-end pharma commercial analytics on synthetic data: SQL Server data-quality pipeline, star schema, Power BI (101 DAX measures), insights.

Pharma commercial performance and sales force effectiveness analysis using Excel, SQL Server and Power BI visibility.

SQL-based pharmaceutical data analysis project using MySQL to analyze drug sales, revenue, inventory, expiry, and supply-chain insights.

Medicare Part D GLP-1 case study: market sizing, growth drivers, state launch priority and back-tested scenarios (CMS data, Python).

Bayesian MMM budget simulator for a fictional oncology brand in Korea, Taiwan and Hong Kong. Synthetic data, lift-test calibration, interactive demo.

Power BI case study on NovaMed’s 2023 sales, customer segments, and product performance across global markets.

US GLP-1 market opportunity and prescriber analytics on CMS Medicare Part D data (2020-2024): market sizing, prescriber segmentation, 2025 forecast, brand-team memo and Tableau extracts.

Decile call lists miss the doctors whose network is converting: graph features vs node2vec/GraphSAGE for HCP launch targeting, measured under a fixed call budget

Every row accounted for: a PySpark medallion lakehouse where bronze_in = silver_kept + quarantined + deduped is asserted per batch and re-runs are checksum-verified no-ops. YAML contracts gate each layer, violations quarantined with reasons. 1.22M rows through bronze/silver/gold in 236.6s on 2 cores. Fabric/Databricks pattern, runs on a laptop.

Interactive Streamlit web app for 365 Emirates Pharma monitoring sales performance, SLA compliance, discount capping, and cold chain storage thresholds.

Pharma commercial analytics on CMS Open Payments + Medicare Part D. dbt + Postgres + Streamlit + Groq LLM. Live demo linked.

Do pharmaceutical payments to physicians still move prescribing in the GLP-1 era? Causal estimates from public CMS data (Medicare Part D linked to Open Payments, 2019 to 2024), with every design first validated on simulated ground truth.